
Céline FROCHOT
255
Documents
Publications
Publications
Nanomaterials and photocatalysis for environment: Applications and characterizationEnvironmental Nanotechnology: Implications and Applications, 99, Elsevier, pp.1-24, 2022, Comprehensive Analytical Chemistry, ⟨10.1016/bs.coac.2021.11.001⟩
Chapitre d'ouvrage
hal-03863266
v1
|
|
Dual imaging and photodynamic therapy anticancer theranostic nanoparticlesPhotonanotechnology for Therapeutics and Imaging, Elsevier, pp.105-146, 2020, ⟨10.1016/B978-0-12-817840-9.00005-9⟩
Chapitre d'ouvrage
hal-03242986
v1
|
|
Different strategies of surface modification to improve the photocatalysis properties: pollutant adsorption, visible activation, and catalyst recoveryHandbook of Smart Photocatalytic Materials, Elsevier, pp.39-57, 2020, ⟨10.1016/B978-0-12-819049-4.00007-6⟩
Chapitre d'ouvrage
hal-03200644
v1
|
|
Production of singlet Oxygen by nanoparticle-bound photosensitizersSanti Nonell and Cristina Flors. Singlet Oxygen : Applications in Biosciences and Nanosciences, Volume 1, Royal Society fo Chemistry, pp.209-223, 2016, Comprehensive Series in Photochemical & Photobiological Sciences, 978-1-78262-038-9. ⟨10.1039/9781782622208-00209⟩
Chapitre d'ouvrage
hal-01288737
v1
|
|
|
Inactivation of Malaria Parasites in Blood: PDT vs Inhibition of Hemozoin FormationAlfonso J. Rodriguez-Morales. Current Topics in Malaria, InTech, 2016, ⟨10.5772/65053⟩
Chapitre d'ouvrage
hal-03242982
v1
|
Inorganic nanoparticles for photodynamic therapySalvatore Sortino. Light-responsive nanostructured systems for applications in nanomedicine, 370, Springer, pp.113-134, 2016, Topics in Current Chemistry, 978-3-319-22942-3. ⟨10.1007/978-3-319-22942-3_4⟩
Chapitre d'ouvrage
hal-01264846
v1
|
|
Multifunctional nanoparticles for theranostic or X-ray-induced photodynamic therapyHerwig Kostron and Tayyaba Hasan. Photodynamic Medicine: From Bench to Clinic, Royal Society of Chemistry, 2016, Comprehensive Series in Photochemical & Photobiological Sciences, 978-1-78262-451-6
Chapitre d'ouvrage
hal-01288745
v1
|
|
How nanoparticles can solve resistance and limitation in PDT efficiencyValentina Rapozzi and Giulio Jori. Resistance to Photodynamic Therapy in Cancer, 5, Springer International Publishing, pp.197-211, 2015, Resistance to Targeted Anti-Cancer Therapeutics, 978-3-319-12729-3. ⟨10.1007/978-3-319-12730-9⟩
Chapitre d'ouvrage
hal-01108682
v1
|
|
Silica-based nanoparticles for photodynamic therapyMichael R. Hamblin; Pinar Avci. Applications of Nanoscience in Photomedicine, Elsevier, pp.449-464, 2015, 978-1-907568-67-1
Chapitre d'ouvrage
hal-01962300
v1
|
|
Targeting strategies in photodynamic therapy for cancer treatmentMichael Hamblin and Ying-Ying Huang. Handbook of Photomedecine, Taylor & Francis - CRC Press, pp.341-352, 2013, 9781439884690
Chapitre d'ouvrage
hal-00761101
v1
|
|
Preventing Societal Health Risks Emerging in the Development Of Nanomedicine - What Should Prevail?Intech Ed. Rijeka - Croatie. Risk Management for the Future - Theory and Cases, Jan Emblemsvag, pp.85-116, 2012, ISBN 978-953-51-0571-8
Chapitre d'ouvrage
hal-00693255
v1
|
|
Preventing societal health risks emerging in the development of nanomedicine - what should prevail?J. EMBLEMSVAG. Risk Management for the future-Theory and cases, Intech Ed. Rijeka, Croatie, pp.85-116, 2012, 978-953-51-0571-8
Chapitre d'ouvrage
hal-00822953
v1
|
|
Targeting strategies in photodynamic therapy for cancers treatmentElena Salvatti. Brain Cancer, Tumor Targeting and Cervical Cancer, Novapublishers, pp.1-38, 2011
Chapitre d'ouvrage
hal-00521043
v1
|
|
Nanoparticles for photodynamic therapy applicationsIntracellular Delivery, Springer Science+Business Media B.V., pp.511-565, 2011, Fundamental Biomedical Technologies,vol. 5, part. 3, ⟨10.1007/978-94-007-1248-5_19⟩
Chapitre d'ouvrage
hal-00579401
v1
|
|
|
Vascular-targeted photodynamic therapy (VTP)Hala Gali-Muhtasib. Advances in Cancer Therapy, InTech, pp.99-122, 2011, 978-953-307-703-1. ⟨10.5772/22935⟩
Chapitre d'ouvrage
hal-00602275
v1
|
Design of experiments applied to the extraction of carotenoids from fruits using accelerated solvent extraction (ASE) or supercritical fluid extraction (SFE)15th International Symposium on Biochromatography and Nanoseparations, May 2021, Nancy, France
Communication dans un congrès
hal-03326867
v1
|
|
Folate-targeted photosensitizer for the treatment of peritoneal metastasis of epithelial ovarian cancer by photodynamic therapy18th Congress of the European Society for Photobiology (ESP), Jul 2019, Barcelone, Spain
Communication dans un congrès
hal-03243806
v1
|
|
X-ray induced PDT and scintillating particlesWorld Congress on Light and Life: Joint 17th International Congress on Photobiology & 18th Congress of the European Society for Photobiology, Aug 2019, Barcelona, Spain
Communication dans un congrès
hal-02415471
v1
|
|
Nanoparticles for X-ray-Induced PDTInternational Conference on Porphyrins and Phthalocyanines, ICCP-10, Jul 2018, Munich, Germany
Communication dans un congrès
hal-02994644
v1
|
|
Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastomaInternational Conference on Porphyrins and Phthalocyanines, ICCP-10, Jul 2018, Munich, Germany
Communication dans un congrès
hal-01845326
v1
|
|
AGuIX® theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of brain tumors17th Congress of the European Society for Photobiology, Sep 2017, Pise, Italy
Communication dans un congrès
hal-02550754
v1
|
|
|
A new display inspired by games to show what you like or don't like in PDTCongress Photodynamic Therapy and Photodiagnosis update, CNRS - Laboratoire Réactions et Génie des Procédés (Céline Frochot); Institut national de la santé et de la recherche médicale (Inserm) (Serge Mordon); Université de Lorraine (Muriel Barberi-Heyob), Oct 2016, Nancy, France. pp.A34-A35, ⟨10.1016/j.pdpdt.2017.01.078⟩
Communication dans un congrès
hal-01715201
v1
|
Vascular targeting for the treatment of glioblastoma by PDT16th International Photodynamic Association World Congress, IPA 2017, Jun 2017, Coimbra, Portugal
Communication dans un congrès
hal-03243053
v1
|
|
Gadolinium-based nanoparticles for the treatment of glioblastoma by MRI-guided photodynamic therapyWorld Molecular Imaging Congress, WMIC 2017, Sep 2017, Philadelphia, United States
Communication dans un congrès
hal-02548177
v1
|
|
New trends in photodynamic therapyJoint Congress of the French and Italian Photochemists and Photobiologists, Société Française de Photobiologie (SFPb) Società Italiana di Fotobiologia (SIFB), Sep 2016, BARI, Italy
Communication dans un congrès
hal-01382653
v1
|
|
Photomolecular beacon ciblant LRP-1, activables par les MMPs pour traiter le glioblastome par thérapie photodynamique.10ème Forum du Cancéropôle Grand-Est, Nov 2016, Nancy, France. pp.11
Communication dans un congrès
hal-01408978
v1
|
|
Use of MR Imaging and proton MR Spectroscopy imaging monitoring to predict tumor response to interstitial photodynamic therapy for glioblastomaPhotodynamic Therapy and Photodiagnosis update, Oct 2016, Nancy, France
Communication dans un congrès
hal-01407476
v1
|
|
Photosensitizer loaded polymer-lipid-peg nanoparticles. Preparation, characterization, photophysical properties and in vitro evaluationsPhotodynamic Therapy and Photodiagnosis update, Oct 2016, Nancy, France. pp.Oral OC-052
Communication dans un congrès
hal-01407716
v1
|
|
Modification of KDKPPR peptide through alanine-scanning technique to investigate the effect on its binding on neuropilin-1 receptor for photodynamic therapy applicationPhotodynamic Therapy and Photodiagnosis update, Oct 2016, Nancy, France
Communication dans un congrès
hal-01498458
v1
|
|
Targeted porphyrins ans nanoparticles for both detection and photodynamic therapyEighth International Conference on Porphyrins and Phthalocyanines, ICPP-9, Jul 2016, Nanjing, China
Communication dans un congrès
hal-03243015
v1
|
|
Interstitial photodynamic therapy for glioblastoma: interest of MRI monitoring to predict iPDT effects.13e Colloque Nano-hybrides, ILM, Lyon 1, May 2016, Porquerolles, France
Communication dans un congrès
hal-01312929
v1
|
|
Nanoparticles and radiation therapies: Main issues1er Congrès Annuel SFNano, Dec 2014, Nancy, France
Communication dans un congrès
hal-01086007
v1
|
|
Magnetic resonance imaging monitoring of interstitial photodynamic therapy for high grade glioma10th International Symposium on Photodynamic Therapy and Photodiagnosis in Clinical Practice, Oct 2014, Brixen, Italy
Communication dans un congrès
hal-01079788
v1
|
|
Optimization of illumination in interstitial photodynamic therapy for high-grade brain tumorsICPA 2014 - International Congress on Photodynamic Applications, May 2014, Dundee, United Kingdom
Communication dans un congrès
hal-01079400
v1
|
|
Nouveaux peptides et peptidométiques pour le ciblage de NRP-1 : intérêt de leur utilisation dans le médulloblastomeJournée d’Echanges sur la Recherche en Cancérologie en Lorraine: La personnalisation du diagnostic et des traitements, Sep 2014, Vandoeuvre-lès-Nancy, France
Communication dans un congrès
hal-01081245
v1
|
|
|
Real-time control of photobleaching trajectory during photodynamic therapyInternational Congress on Photodynamic Applications, ICPA 2014, May 2014, Dundee, United Kingdom
Communication dans un congrès
hal-01078940
v1
|
Interest of photosensitizer-loaded nanoparticles for targeted photodynamic therapyColloque Inter-régional Grand-Est de Recherche Translationnelle en Oncologie, ONCOTRANS 2011, Sep 2011, Nancy, France
Communication dans un congrès
hal-00654208
v1
|
|
|
Contributions of experiment designs in photodynamic therapy: photosensitizer design, treatment analysis and optimization.13th World Congress of the International Photodynamic Association, IPA 2011, May 2011, Innsbruck, Austria. pp.CDROM
Communication dans un congrès
hal-00597950
v1
|
Preparation, characterization and cellular studies of photosensitizer-loaded lipid nanoparticles for photodynamic therapyConference on Optical Methods for Tumor Treatment and Detection - Mechanisms and Techniques in Photodynamic Therapy XX, Jan 2011, San Francisco, United States. pp.Article Number: 78860Y, ⟨10.1117/12.876125⟩
Communication dans un congrès
hal-00822855
v1
|
|
Nanoparticules multifonctionnelles pour la thérapie photodynamiqueColloque Nanohybrides 7, May 2010, Porquerolles, France
Communication dans un congrès
hal-00547623
v1
|
|
New multifunctional platform for diagnosis and photodynamic therapy applicationsESP 2010 Photobiology school, Jun 2010, Brixen, Italy
Communication dans un congrès
hal-00547290
v1
|
|
Nanoparticles for MRI and vascular photodynamic treatment of brain tumours8th International Symposium on Photodynamic Therapy and Photodiagnosis in Clinical Practice, Oct 2010, Brixen, Italy. pp.CDROM
Communication dans un congrès
hal-00547279
v1
|
|
The use of nanoparticles for photodynamic therapy agent delivery8th International Symposium on Photodynamic Therapy and Photodiagnosis in Clinical Practice, Oct 2010, Brixen, Italy
Communication dans un congrès
hal-00547619
v1
|
|
Selective antitumour effect in Photodynamic Therapy mediated by photo-activatable molecules, activated by endopeptidases8th International Symposium on Photodynamic Therapy and Photodiagnosis in Clinical Practice, Oct 2010, Brixen, Italy
Communication dans un congrès
hal-00547620
v1
|
|
Selective anti-tumor effect in photodynamic therapy mediated by photo-activable molecules activated by endopeptidases8th International Symposiumon Photodynamic Therapy and Photodiagnosis in Clinical Practice, Oct 2010, Brixen, Italy. pp.CDROM
Communication dans un congrès
hal-00547293
v1
|
|
Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improve stability properties8th International Symposium on Photodynamic Therapy and Photodiagnosis in Clinical Practice, Oct 2010, Brixen, Italy
Communication dans un congrès
hal-00547622
v1
|
|
Thérapie photodynamique ciblant la neuropiline-1 : intérêt des pseudopeptides biologiquement plus stablesGDR 3049 Photomed, Sep 2010, Paris, France
Communication dans un congrès
hal-00548924
v1
|
|
New multifunctional platform for diagnosis and photodynamic therapy applicationsJournée des jeunes chercheurs de la Société de Chimie thérapeutique, Faculté de Pharmacie de l'Université Paris-Descartes, Feb 2010, Paris, France
Communication dans un congrès
hal-00547626
v1
|
|
Interest of Click chemistry in theranostic for neuropilin-1 targetingProbes for peptide Sciences: Design and methodological development, Apr 2010, Paris, France
Communication dans un congrès
hal-00547963
v1
|
|
Photodynamic therapy targeting neruropilin-1: interest of pseudopeptidesProbes for peptide Sciences: design and methodological development, Apr 2010, Paris, France
Communication dans un congrès
hal-00547624
v1
|
|
Applications of experimental designs in photodynamic therapy. Towards an integrative approach of development8th International Symposium on Photodynamic Therapy and Photodiagnosis in Clinical Practice, Oct 2010, Brixen, Italy
Communication dans un congrès
hal-00547621
v1
|
|
The use of nanoparticles for photodynamic therapy agent delivery - 8th International Symposium on Photodynamic Therapy and Photodiagnosis in Clinical PracticeThe use of nanoparticles for photodynamic therapy agent delivery, 2010, Brixen, Italy
Communication dans un congrès
hal-00846658
v1
|
|
Nanoparticles for MRI and vascular photodynamic treatment of brain tumorXXVèmes Journées scientifiques du GTRV (Groupement thématique de Recherche sur la Vectorisation), Dec 2010, Toulouse, France
Communication dans un congrès
hal-00548923
v1
|
|
Selective anti-tumor effect in photodynamic therapy mediated by photo-activable molecules activated by endopeptidasesJournée Jeunes Chercheurs de la Société de Chimie Thérapeutique (SCT), Feb 2010, Nancy, France
Communication dans un congrès
hal-00555141
v1
|
|
Folic acid and peptides in targeting strategies13th International Photodynamic Association World Congress, IPA2011, May 2011, Innsbruck, Austria. pp.CDROM
Communication dans un congrès
hal-00555160
v1
|
|
Interest of Click chemistry in theranostic for neuropilin-1 targetingInternational training group-Graduierten Kolleg 532, Mar 2010, Nancy, France
Communication dans un congrès
hal-00555142
v1
|
|
Nanoparticules multifonctionnelles pour la thérapie photodynamique - Nanohybrides 7Nanoparticules multifonctionnelles pour la thérapie photodynamique, May 2010, Porquerolles, France
Communication dans un congrès
hal-00846662
v1
|
|
Nanoparticules multifonctionnelles pour des applications biomédicales - 6ème journée CLARA.Nanoparticules multifonctionnelles pour des applications biomédicales, Oct 2010, Montpellier, France
Communication dans un congrès
hal-00846661
v1
|
|
Preparation, characterization and cellular studies of photosensitizerloaded lipid nanoparticles for photodynamic therapy.GDR Photomed “Médicaments Photoactivables – Photochimiothérapie", Sep 2009, Limoges, France
Communication dans un congrès
hal-00437094
v1
|
|
Validation de l'efficacité anti-vasculaire de la thérapie photodynamique par ciblage de neuropiline-1 : intérêt des nanoparticules multifonctionnelles.GDR Photomed “Médicaments Photoactivables – Photochimiothérapie'', Sep 2009, Limoges, France
Communication dans un congrès
hal-00437119
v1
|
|
Pour une amélioration de la thérapie photodynamique anti-cancéreuse : Adressage de quantum dots par l'acide folique.GDR Photomed “Médicaments Photoactivables – Photochimiothérapie'', Sep 2009, Limoges, France
Communication dans un congrès
hal-00437117
v1
|
|
Optimisation des modalités de la PDT par méthodologie des plans d'expériences.GDR Photomed “Médicaments Photoactivables – Photochimiothérapie'', Sep 2009, Limoges, France
Communication dans un congrès
hal-00437114
v1
|
|
Pour une amélioration de la thérapie photodynamique (PDT) anticancéreuse : Adressage de Quantum Dots par l'acide foliqueJournées de Printemps du groupe français de photochimie, photophysique et photosciences (GFP2P), May 2009, Nancy, France
Communication dans un congrès
hal-00379499
v1
|
|
Study of low-molecular-weight organogelators1st ERA-Chemistry Flash Conference, Mar 2007, Autrans, France
Communication dans un congrès
hal-00371531
v1
|
|
Relations Photosciences et Société : 40 ans d'activités de Marie-Laure ViriotJournées de Printemps du groupe français de photochimie, photophysique et photosciences (GFP2P), May 2009, Nancy, France
Communication dans un congrès
hal-00379460
v1
|
|
Neuropilin-1 targeting photosenssitization-induced thrombogenic effects via tissue factor release13th Congress of European Society for Photobiology, ESP 2009, Sep 2009, Wroclaw, Poland. pp.CDROM
Communication dans un congrès
hal-00437069
v1
|
|
L'utilisation de nanoparticules comme vecteurs de photosensibilisateurs adressés pour la thérapie photodynamique anticancéreuseJournées de Printemps du groupe français de photochimie, photophysique et photosciences (GFP2P), May 2009, Nancy, France
Communication dans un congrès
hal-00379483
v1
|
|
Elaboration, caractérisation photophysique et biologique de molécules photoactivables anti-cancéreuses.GDR Photomed “Médicaments Photoactivables – Photochimiothérapie'', Sep 2009, Limoges, France
Communication dans un congrès
hal-00437115
v1
|
|
Design and photophysical characterization of a photodynamic molecular beacon for PDT13th Congress of European Society for Photobiology, ESP 2009, Sep 2009, Wroclaw, Poland. pp.CDROM
Communication dans un congrès
hal-00437070
v1
|
|
Influence of the gelator structure and solvent on the organisation and chirality of the self-assembling fibrillar networksJournée scientifique du PPF Matériaux Fibreux et Arbolor, Nov 2007, Nancy, France
Communication dans un congrès
hal-00374051
v1
|
|
Suivi de la cinétique de polymérisation en miniémulsion par spectroscopie de fluorescenceJournées de Printemps du groupe français de photochimie, photophysique et photosciences (GFP2P), May 2009, France
Communication dans un congrès
hal-00379494
v1
|
|
Intérêt des pseudopeptides pour une PDT anti-vasculaire adressée.GDR Photomed “Médicaments Photoactivables – Photochimiothérapie'', Sep 2009, Limoges, France
Communication dans un congrès
hal-00437122
v1
|
|
Intérêt des nanoparticules pour la thérapie photodynamique en cancérologie : Concepts & Innovations.GDR Photomed “medicaments Photoactivables – Photochimiothérapie'', Sep 2009, Limoges, France
Communication dans un congrès
hal-00437112
v1
|
|
Response surface methodology: an experimental approach to optimize in vivo modalities of photodynamic therapyPhotodynamic Therapy and Photodiagnosis in Clinical Practice, PDT 2008, Oct 2008, Brixen, Italy. pp.Poster session B-01
Communication dans un congrès
hal-00338304
v1
|
|
Strategies to increase the selectivity of photosensitizers for photodynamic therapy7th International Symposium on Photodynamic Therapy and Photodiagnosis in Clinical Practice, Oct 2008, Brixen/Bressanone, Italy
Communication dans un congrès
hal-00369880
v1
|
|
Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study1st Conference of the European Platform for Photodynamic Medicine, EPPM-1, Mar 2008, Dubrovnic, Croatia
Communication dans un congrès
hal-00323710
v1
|
|
Photo-activable molecules for anti-cancer applicationsSéminaire des Universités Srinakharinwirot et Mahidol de Bangkok, Apr 2008, Bangkik, Thailand
Communication dans un congrès
hal-00369877
v1
|
|
Nouvelles stratégies de ciblage en Thérapie PhotodynamiqueSéminaire de l'U703-INSERM de Lille, Jul 2008, France
Communication dans un congrès
hal-00369878
v1
|
|
Basic principles of Photodynamic Therapy (PDT)7th International Symposium on Photodynamic Therapy and Photodiagnosis in Clinical Practice, Oct 2008, Brixen/Bressanone, Italy
Communication dans un congrès
hal-00369879
v1
|
|
Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice.20th Meeting of the European Association for Cancer Research, EACR'20, Jul 2008, Lyon, France. pp.25, ⟨10.1016/S1359-6349(08)71273-4⟩
Communication dans un congrès
istex
hal-00323709
v1
|
|
Nanoparticules pour la Thérapie photodynamique anti-cancéreuse : Concept & Innovations Cibler neuropiline-1 pour favoriser l'effet anti-vasculaire de la thérapie phodynamiqueColloque NanoHybrides V, Jun 2008, Porquerolles, France
Communication dans un congrès
hal-00323573
v1
|
|
An innovative method to obtain porous PLLA scaffold with spherical and interconnected poresSéminaire de l'Ecole Doctorale EMMA, May 2007, Nancy, France
Communication dans un congrès
hal-00371528
v1
|
|
Suivi de la cinétique de polymérisation en miniémulsion par spectroscopie de fluorescenceClub Emulsion 2007, Sep 2007, Lyon, France
Communication dans un congrès
hal-00374058
v1
|
|
Etude de l'affinité de pseudopeptides vis-à-vis des récepteurs au VEGF : Vers l'élaboration de médicaments photo-activables conjugués plus stables pour des applications en thérapie photodynamique anticancéreuseXXVII Congrès de la Société Francophone de Lasers Médicaux, Mar 2007, Paris, France
Communication dans un congrès
hal-00145655
v1
|
|
Biofonctionnalisation de nanoparticules multifonctionnellesCongrès Nano-Hybrides 4, Jun 2007, Centre IGESA, Marana (Haute-Corse), France
Communication dans un congrès
hal-00374056
v1
|
|
Des peptides adresseurs de photosensibilisants pour des applications en thérapie photodynamique anti-cancéreuse15ème Congrès du Groupe Français des Peptides et Protéines, May 2007, Dinard, France
Communication dans un congrès
hal-00371533
v1
|
|
Influence of the gelator structure and solvent on the organisation and chirality of the self-assembling fibrillar network3rd France-Russia seminar, Nov 2007, Metz, France
Communication dans un congrès
hal-00371530
v1
|
|
Confocal microscopy observation of CHO cells cultivated in presence of fluorescence-labelled rapeseed peptides20th Meeting of the European Society for Animal Cell Technology, Jun 2007, Dresden, Germany
Communication dans un congrès
hal-00371532
v1
|
|
An innovative method to obtain porous PLLA scaffold with spherical and interconnected pores.Engineering tissues : replace - repair - regenerate, Mar 2007, Sea Pines - Hilton Head Island, SC, United States
Communication dans un congrès
hal-00371526
v1
|
|
Targeted photodynamic therapyXXI IUPAC Symposium on Photochemistry, Kyoto, Apr 2006, Kyoto, Japan
Communication dans un congrès
hal-00121037
v1
|
|
A chlorin-ATWLPPR conjugate as new neuropilin-1-targeting photosensitizer designed to potentiate the vascular effect of PDT : pharmacokinetic and biodistribution analysis.6th International Symposium on Photodynamic Diagnosis and Therapy in Clinical Practice, Oct 2006, Brixen, Italy
Communication dans un congrès
hal-00121025
v1
|
|
Intracellular localization and in vitro stability of a photosensitizer conjugated to the NRP-1 receptor-binding ATWLPPR peptide.97th American Association for Cancer Research Annual Meeting, Apr 2006, Washington,DC, United States. pp.CDROM
Communication dans un congrès
hal-00121030
v1
|
|
A chlorin-ATWLPPR conjugate as new neuropilin-1-targeting photosensitizer designed to potentiate the vascular effect of PDT: in vitro and in vivo results.6th International Symposium on Photodynamic Diagnosis and Therapy in Clinical Practice, Oct 2006, Brixen, Italy
Communication dans un congrès
hal-00121034
v1
|
Lutter contre le cancer avec le ciblage moléculaire2018
Autre publication scientifique
hal-03243000
v1
|
|
|
Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study.2015
Autre publication scientifique
hal-01183340
v1
|
Supercritical CO2 extraction of carotenoids from persimmon fruit:design of experiment and modeling16th European Meeting on Supercritical Fluids, Apr 2017, Lisbon, Portugal. 2017
Poster de conférence
hal-03323750
v1
|
|
AGUIX® theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of brain tumorsPhotodynamic Therapy and Photodiagnosis update, Oct 2016, Nancy, France. , 17, pp.A71, 2017, ⟨10.1016/j.pdpdt.2017.01.161⟩
Poster de conférence
hal-01408883
v1
|
|
PDTeam’s project: Targeting to improve PDT selectivityCongrès Photodynamic Therapy and Photodiagnosis update, Oct 2016, Nancy, France. , 2016, ⟨10.1016/j.pdpdt.2017.01.116⟩
Poster de conférence
hal-01498467
v1
|
|
Ultrasmall gadolinium-based nanoparticles designed for photodynamic therapy (PDT) guided by MRIPhotodynamic Therapy and Photodiagnosis update, Oct 2016, Nancy, France. , Photodiagnosis and Photodynamic Therapy, 17, pp.A60, 2017, ⟨10.1016/j.pdpdt.2017.01.136⟩
Poster de conférence
hal-01498485
v1
|
Enveloppe Solelau: Nouveau procédé de brachythérapie avec couplage nano-PDTN° de brevet: Pli 453732. 2012
Brevet
hal-00787393
v1
|
|
Système générant des espèces réactives de l'oxygène par utilisation comme médicament dans le traitement du cancerFrance, N° de brevet: 11-51593. 2011
Brevet
hal-00783990
v1
|
Étude d'un décapeptide à activité de type benzodiazépine issu d'une protéine du lait bovinMédecine humaine et pathologie. Institut National Polytechnique de Lorraine, 1997. Français. ⟨NNT : 1997INPL104N⟩
Thèse
tel-01750967
v1
|
Chargement...
Chargement...